Ampio Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2006
Net Income	-8.63	-8.47	-12.49	-16.5	-8.68	Upgrade
Depreciation & Amortization	0.25	1.05	1.09	1.18	1.27	Upgrade
Share-Based Compensation	0.16	0.95	2.72	1.28	0.41	Upgrade
Other Operating Activities	-0.34	-14.66	-5.42	-0.69	-8.38	Upgrade
Operating Cash Flow	-8.56	-21.13	-14.09	-14.73	-15.38	Upgrade
Capital Expenditures	0	0	-0.1	-0.06	-0.02	Upgrade
Investing Cash Flow	0	0	-0.1	-0.06	-0.02	Upgrade
Common Stock Issued	0.1	-0.03	33.01	26.19	14.35	Upgrade
Share Repurchases	0	-0	-0.19	0	0	Upgrade
Other Financing Activities	-	0.03	-2.47	-0.59	-14.34	Upgrade
Financing Cash Flow	0.1	-0	30.73	25.61	0.01	Upgrade
Net Cash Flow	-8.56	-21.24	16.55	10.81	-1.05	Upgrade
Free Cash Flow	-8.56	-21.13	-14.19	-14.79	-15.41	Upgrade
Free Cash Flow Per Share	-10.57	-28.04	-21.13	-24.84	-32.50	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.